In the study by Rebours et al., based on the French national cohort of patients with a PRSS1 gene mutation, the cumulative risk of pancreatic cancer at the age of 50, 60, and 75 years was 10%, 19%, and 53.5%, respectively. The gene discussed is PRSS1; the disease is familial pancreatic carcinoma.